Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda's Alogliptin Suffers Major Setback, Delaying Drug Launch Until 2012 Or Later

Jun 30 2009

• By Ellen Licking

Related Content

PPI Market Snapshot: Kapidex Joins The Party Fashionably Late

Feb 09 2009

Takeda Positions Uloric To Gout Patients In Need Of Better Control

Feb 23 2009

Velcade Double Entendre Raises Red Flags At FDA Over Reminder Ads

Jun 24 2009

After Combining Assets, Takeda/Millennium Outline Oncology Strategy

Mar 27 2009

Genentech Exec Heads East To Take The Reins Of Cancer-Focused Start-up Agios

May 27 2009

Takeda Reaffirms Oncology Goals With $8.8 Billion Millennium Acquisition

Apr 10 2008

Carfilzomib And Pomalidomide Pass Phase II

Dec 11 2008

Takeda Makes $1 Billion Move For Amgen Development Rights

Feb 04 2008

ASH Data Give Millennium’s Velcade A Boost, Raise Bar For Competitors

Dec 15 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window